Power Law company profile

Reata Pharmaceuticals

Biotech & Life Sciences · Plano, United States · Founded 2002 · IPO 2016 Unicorn

Biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases

Valuation

$6.40B

Market cap · 2026

Revenue

$2.2M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

6 investors on Reata Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Startech Early Ventures

Series B+ 5 investors entered at this stage

CPMG

Novo Seeds

The University of Texas System

Cardinal Investment Co.

Novo Holdings

Global footprint

Where Reata Pharmaceuticals has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States95.1%

🇫🇷 France2%

🇬🇧 United Kingdom2%

🇨🇭 Switzerland1.9%

🇮🇹 Italy1.9%

5 countries shown

Patent intelligence

$354M patent portfolio · 76 active families

Estimated portfolio value

$354M

5.5% of market cap · comparable to top peer Actelion Pharmaceuticals ($361M)

76 active patent families

Where Reata Pharmaceuticals innovates Medicinal chemistryPharmaceutical SubstancesPharmaceutical drugPerylene derivativesPharmacology

Where Reata Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Reata Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Reata Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Reata Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Reata Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles